Particle.news

Download on the App Store

Trump Orders Swift Filling and Expansion of Strategic API Reserve

HHS must identify 26 critical drugs within 30 days to launch six-month API stockpiles aimed at shoring up a supply chain that relies largely on foreign producers.

The SAPIR was established in 2020 by the Trump administration in response to the Covid-19 pandemic. Credit: GarryKillian via Shutterstock.com.

Overview

  • The August 13 executive order tasks the Office of the Assistant Secretary for Preparedness and Response with compiling a list of roughly 26 critical medicines and identifying existing funds for SAPIR preparation.
  • Agencies have 120 days to ready the current Strategic Active Pharmaceutical Ingredients Reserve and must begin placing six-month API supplies into storage within 30 days of repository certification.
  • Within 90 days, ASPR must update its 2022 list of 86 essential drugs and submit a plan that includes a cost estimate and proposal to open a second SAPIR facility within one year.
  • The order emphasizes a preference for domestically manufactured APIs even though only about 10–11 percent of the nation’s active pharmaceutical ingredients are currently produced in the United States.
  • No new appropriations are authorized; the directive requires agencies, with OMB support, to repurpose existing budgetary resources under current legal authorities.